Q32 Bio (STU:DB0) Net Margin %: 0.00% (As of Mar. 2026)


STU:DB0 Q32 Bio Inc STU:DB0
17 GF Score
Price €9.65
! 2 Warning Signs
View Full Analysis

What is Q32 Bio Net Margin %?

Q32 Bio STU:DB0 -5.76% 17 Net Margin % is 0.00% as of Mar. 2026. GuruFocus rates STU:DB0 with a GF Score™ of 17/100. The stock has 2 warning signs investors should review. Among 947 Biotechnology companies, Q32 Bio ranks better than 96.41% on this metric.

Net margin is calculated as Net Income divided by its Revenue. Q32 Bio's Net Income for the three months ended in Mar. 2026 was €-6.58 Mil. Q32 Bio's Revenue for the three months ended in Mar. 2026 was €0.00 Mil. Therefore, Q32 Bio's net margin for the quarter that ended in Mar. 2026 was 0.00%.

The historical rank and industry rank for Q32 Bio's Net Margin % or its related term are showing as below:

STU:DB0' s Net Margin % Range Over the Past 10 Years
Min: -643.65   Med: 55.49   Max: 808.04
Current: 61.86

STU:DB0's Net Margin % is ranked better than
96.41% of 947 companies
in the Biotechnology industry
Industry Median: -89.33 vs STU:DB0: 61.86

Q32 Bio  (STU:DB0) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.

Q32 Bio Net Margin % Related Terms

Q32 Bio Net Margin % Historical Data

* Premium members only.

The historical data trend for Q32 Bio's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Q32 Bio Net Margin % Chart

Q32 Bio Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Net Margin %
0.00 -643.61 808.03 0.00 55.49

Q32 Bio Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 107.43 0.00

STU:DB0 vs ABOS, TNYA, MDWD: Net Margin % Comparison

For the Biotechnology subindustry, Q32 Bio's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Q32 Bio Net Margin % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Q32 Bio's Net Margin % distribution charts can be found below:

* The bar in red indicates where Q32 Bio's Net Margin % falls into.


STU:DB0
17GF Score
Q32 Bio Inc STU:DB0
Net Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Q32 Bio Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Q32 Bio's Net Margin for the fiscal year that ended in Dec. 2025 is calculated as

Net Margin=Net Income (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=25.467/45.891
=55.49 %

Q32 Bio's Net Margin for the quarter that ended in Mar. 2026 is calculated as

Net Margin=Net Income (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=-6.582/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Margin % →
What does a Net Margin % of 0.00% mean?
Q32 Bio (STU:DB0) has a Net Margin % of 0.00% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Q32 Bio and its competitors. According to the industry distribution chart, Q32 Bio ranks #34 out of 947 companies in the Biotechnology industry, placing it in the top 3.6%.
Is Q32 Bio's Net Margin % too high?
Q32 Bio's current Net Margin % is 0.00%. Based on the distribution chart, Q32 Bio ranks #34 out of 947 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, Q32 Bio has a GF Score™ of 17/100, reflecting its overall financial health beyond just this single metric.
How does Q32 Bio's Net Margin % compare to ABOS and TNYA?
According to the Biotechnology industry distribution chart, Q32 Bio ranks #34 out of 947 companies for Net Margin %. This places Q32 Bio in the top 4% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Biotechnology company?
A good Net Margin % depends on the Biotechnology industry context. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Q32 Bio and its competitors. Q32 Bio's current Net Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Q32 Bio stock overvalued right now?
Q32 Bio (STU:DB0) has a current Net Margin % of 0.00%. The current Net Margin % is 0.00%. Q32 Bio's overall GF Score™ is 17/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Q32 Bio (STU:DB0), the current Net Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Q32 Bio Business Description

Other Exchanges QTTB:USADB0:Germany
Address 830 Winter Street, Waltham, MA, USA, 02451
Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to restore healthy immune balance in patients with alopecia areata (AA) and other autoimmune and inflammatory diseases driven by immune dysfunction. Its product candidate, bempikibart (ADX 914), is a fully human anti-interleukin 7 receptor alpha (IL-7R) antagonist monoclonal antibody designed to block signaling mediated by interleukin 7 (IL 7) and thymic stromal lymphopoietin (TSLP) and re-regulate adaptive immune function. The company has completed two Phase 2a clinical trials evaluating bempikibart, SIGNAL AA Part A for the treatment of alopecia areata and SIGNAL AD for the treatment of atopic dermatitis (AD).
17GF Score

Get the complete analysis for STU:DB0

Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€9.65
Price